Normal Pressure Hydrocephalus

Normal Pressure Hydrocephalus (NPH) is a neurological condition characterized by the abnormal accumulation of cerebrospinal fluid (CSF) in the brain's ventricles, causing ventricular enlargement. Despite this enlargement, CSF pressure measured during lumbar puncture remains normal or only intermittently elevated. NPH presents classically with a clinical triad of gait disturbance, cognitive decline, and urinary incontinence.

• Idiopathic NPH (iNPH): Arises spontaneously without an identifiable cause; predominantly seen in older adults.
• Secondary NPH (sNPH): Develops as a complication of prior intracranial events, including subarachnoid hemorrhage, head trauma, meningitis, or cranial surgery.

NPH is caused by impaired resorption of CSF through the arachnoid villi into the venous sinuses, or increased outflow resistance. This results in ventricular dilation, exerting mechanical stretch and shear forces on periventricular white matter tracts (e.g., the corona radiata). Chronic ventriculomegaly leads to localized ischemia, interstitial edema, and axonal dysfunction in pathways regulating motor function, cognition, and bladder control.

• Prevalence: Increases with age; estimated at 1.4% to 5.9% in individuals over 80 years old.
• Demographics: Typically diagnosed in patients over 60 years of age. There is no significant gender predisposition.

• Advanced age (>60 years)
• Hypertension and cardiovascular disease
• Prior head trauma or intracranial hemorrhage
• History of meningitis or central nervous system infections
• Diabetes mellitus

• Gait Assessment: Decreased step height, wide-based stance, and multiple steps required to execute a 180-degree turn.
• Neurological Exam: Lower extremity hyperreflexia and mild spasticity; sensory examination is typically normal.
• Cognitive Assessment: Frontal release signs (e.g., grasp reflex) in advanced cases.

• A. Clinical Assessment: Assessment of the classic clinical triad and formal gait velocity testing.
• B. Laboratory Testing: CSF analysis to rule out infection and evaluate opening pressure.
• C. Imaging Studies: Brain MRI to assess ventricular morphology.
• D. Functional Tests: Lumbar tap test (gait evaluation before and after removing 30–50 mL of CSF).
• E. Biopsy Findings: Not indicated.
• F. Genetic Testing: Generally not indicated.
• G. Differential Diagnosis: Differentiating from Alzheimer's disease and Parkinson's disease.

Test Name: Cerebrospinal Fluid (CSF) Analysis
Type: Spinal Fluid Test
Purpose: To rule out mimicking pathologies and document opening pressure.
Expected Findings: Normal opening pressure (70–200 mm H2O), normal protein, glucose, and cell counts.
Interpretation: Normal findings support NPH; elevated white blood cells or proteins suggest infectious, inflammatory, or neoplastic etiologies.

Brain MRI: Purpose: Evaluate structural ventricular enlargement. Typical Findings: Ventriculomegaly with an Evans Index > 0.3, periventricular hyperintensities, and narrowing of high-convexity sulci with dilation of Sylvian fissures (DESH sign). Clinical Importance: Differentiates NPH from generalized brain atrophy (ex-vacuo ventriculomegaly).

• Alzheimer's Disease: Cognitive decline precedes gait impairment; MRI shows prominent cortical and hippocampal atrophy.
• Parkinson's Disease: Characterized by resting tremor, rigidity, and bradykinesia; gait features parkinsonian festination rather than a magnetic gait.
• Vascular Dementia: Stepwise cognitive decline with clear focal neurological deficits and extensive cortical/subcortical infarcts on MRI.

• Subdural hematomas or hygromas (due to CSF overdrainage)
• Shunt infection (e.g., meningitis or peritonitis)
• Shunt obstruction or mechanical failure
• Progressive, irreversible cognitive impairment if untreated

Surgical shunting provides symptomatic improvement in up to 70-80% of properly selected patients. Gait symptoms show the highest rate of improvement, followed by urinary control and cognitive deficits. Early intervention is associated with significantly better clinical outcomes.

• Primary Prevention: Management of cardiovascular risk factors.
• Secondary Prevention: Early clinical recognition and screening of patients presenting with atypical gait and cognitive decline to prevent irreversible neurological damage.

The following homeopathic remedies have been historically indicated for symptoms associated with Normal Pressure Hydrocephalus. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Epworth Sleepiness Scale (ESS)

Evaluates daytime sleepiness levels to screen for sleep apnea, narcolepsy, or chronic sleep deprivation disorders.